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“Abstract.” Phenolic compounds are bioactive substances widely distributed in the 
vegetable kingdom. They act as natural antioxidants, and their presence contributes to 
the color, flavor and aroma of food. This group of micronutrients is composed of one or 
more aromatic benzene rings with one or more hydroxyl groups and their redox 
properties are related with their chemical structure characteristics. The knowledge of 
their redox potentials may help the food industry, because when phenolic compounds 
are oxidized they could affect the quality of the wines, beers, grape juices, etc. 
Coumarins are a large family of compounds, of natural and synthetic origin, that 
show important biological activities. Therefore, they occupy an important place in the 
study of natural products and synthetic organic chemistry. Recent studies pay special 
attention to their antioxidative, anticarcinogenic and enzymatic inhibition properties. 
Their preparation, and the versatility of the synthetic methodology, allowed us obtaining 
a wide family of compounds with substituent in different positions in the molecule. The 
election of these derivatives has considered the later pharmacological evaluation. 
The investigation of the properties of these compounds, the study of the structural 
pattern and the elucidation of their biological role is of great interest for further 
development of coumarin-like antioxidant drugs. The electrochemical behaviour of a 
group of differently substituted hydroxycoumarins was investigated using cyclic, 
differential pulse and square wave voltammetry, in aqueous media at a glassy carbon 
electrode over the whole pH range. The antioxidant reactivity and capacity were also 
evaluated through a competition assay with hydroxyl radical (OH•) and ORAC-FL 
methodology. Number and positions of the hydroxyl groups were important factors in 
the antioxidant activities against peroxyl and hydroxyl radicals of the coumarin 
derivatives. 
 
*To whom correspondence should be addressed – e-mail: mariajoao.correiapinto@rai.usc.es 
 
1. Introduction 
In recent years, phytochemical compounds have been showing a great interest due to 
their presence in bioactive dairy products. Fruits, vegetables, oil and wine have been 
studied as health protectors because of the antioxidant potential of their phenolic 
compounds. These compounds are known to be the most common secondary 
metabolites in the vegetable kingdom.
1,2,3 
The fusion of a pyrone with a benzene ring gives rise to a class of heterocyclic 
compounds known as benzopyrones or coumarins.
4
 Coumarins are a wide group of 
compounds present in remarkable amounts in the nature.
5
 Representatives of this group 
occur in the vegetable kingdom, either in free or combined state.
6
 Due to their structural 




Coumarins have been attracting considerable interest due to their numerous 
biological activities, usually associated to low toxicity, depending on their substitution 
pattern.
8
 There are many possible permutations offered by substitution and conjugation, 
and this readily explains why so many synthetic analogues featuring coumarin structural 
motif are investigated due to their wide range of biological properties.
9
 In the literature, 













 and enzymatic inhibitors.
18,19,20,21
 
Indeed, some coumarins are now commercially available as medicines.  
 
2. Chemistry 
The coumarin derivatives 1-10
15,22,23,24
 were efficiently synthesized according to the 
protocol outlined in Scheme 1. The general conditions and the compounds 
characterization were described in the experimental section. 
Perkin condensation of differently substituted ortho-hydroxybenzaldehydes with the 
corresponding arylacetic acids, using N,N’-dicyclohexylcarbodiimide (DCC) as 
dehydrating agent, in DMSO, afforded the 3-arylcoumarins 1-5. Compounds 6-10 were 
synthesized starting from the respective methoxy/ethoxy derivatives 1-5 by hydrolysis 







Reagents and conditions: (i) DCC, DMSO, 110 ºC, 24 h; (ii) HI, AcOH, Ac2O, 110 ºC, 3 h. 
 
3. Results and discussion 
All the described 3-arylcoumarins (compounds 1-10) were efficiently synthesized, 
characterized and evaluated for their antioxidant functionality. Relevant aspects 
concerning the electrochemistry of this new series of synthesised coumarins can be 
obtained. Considering that the electrochemical behaviour of these compounds depends 
on their structural features, useful information on their antioxidant functionality can be 
drawn. For this purpose cyclic (CV), differential pulse (DPV), at different pH values, 
and ORAC-FL experiments for some of the hydroxyl derivatives were performed. 
Voltammetric study of compound 6 at pH 7.0, figure 1, shows on the first scan an 
oxidation peak at Ep1= + 0.650 V corresponding with an irreversible reaction. A value 
of Ep-Ep/2= + 0.050 V indicates that one electron is involved in the first oxidation 
process. A reduction peak, on the inverse sense, at Ep2c= + 0.044 V could also be seen, 
corresponding to the reduction of the oxidation products formed during oxidation of 
peak P1. The reversibility of peak 2 was confirmed in the second scan where a new 
oxidation peak appears at lower potentials, Ep2a= + 0.076 V. This reversible oxidation 
process corresponding with peak P2 occurs with transference of two electrons. 
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When two hydroxyls groups are present in the molecule, as compound 7, the 
differential pulse voltammogram should show two oxidation peaks due to both 
oxidizable groups. Figure 2A presents the first and second scan of compound 7. The 
first one shows an oxidation peak with a W1/2 ~200 mV suggesting that could be two 
oxidation peaks. This is confirmed on figure 2B, on the second scan, when the baseline 
is subtracted. First scan shows also another oxidation peak at lower potentials, called P2 
at Ep2= + 0.167 V. This potential value can be compared with that one for a catecol 
group. On the second scan an oxidation product peak, P3, appears at Ep3= + 0.047 V. As 
was seen before though CV, P3 corresponds to the oxidation product formed after P1 
oxidation. The strong adsorption of the oxidation products, which blocked the electrode 
surface, makes possible to observe more easily on the second scan both oxidation peaks, 
P1 and P1’. Oxidation processes due to P1 and P1’ occur with one electron transference in 
each case. A value of W1/2
P3
= + 0.057 V indicates that one electron is involved on the 
oxidation process. The value of W1/2 obtained for P2 was + 0.054 V indicating that two 
electron are involved in the oxidation process. This would confirm that P2 is an 
oxidation product of P1 corresponding with a catecol group.  
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Figure 2. Differential pulse voltammograms of compound 7, 0.5 mM at pH 7.0, 0.2M phosphate buffer. 
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The peak P1 potential of each compound is displaced to more negative values with 
increasing pH. A slope of proximately + 0.059 V suggests that the oxidation processes 
involve the same number of electrons and protons. P1 and P1’ occurs by transference of 
one electron and one proton whereas, P2 and P3, both oxidation products, occur by 
transference of two electrons and two protons. 
Oxidation product peaks of each compound involved two electrons and two protons. 
Oxidation products showed a very low oxidation potential. This behaviour, which is 
related to their molecular structure, clearly shows their good antioxidant properties. 
Also, ORAC-FL indexes were calculated by fluorescence measurements, comparing 
with the reference compound Trolox. The values obtained in ORAC-FL experiment are 
showed in table 1. Positions of the hydroxyl groups were important factors in the 
antioxidant activities against peroxyl and hydroxyl radicals of the coumarins 
derivatives. 
Table 1. ORAC-FL results of some of the described compounds 
Compounds ORAC-FL 








We synthesized a new series of compounds using an efficient and versatile synthetic 
route. The experimental results demonstrated that using electrochemical methods as CV 
and DPV, it can be clarified the mechanism of electron transfer of a new series of 3-
arylcoumarins. Compound 7 is the best antioxidant candidate since it has the lowest 
oxidative potential and also the highest ORAC-FL value of this new series.  
 
5. Experimental section 
General Procedure for the Preparation of 3-phenylcoumarins (1-5). A solution of 
hydroxybenzaldehyde (7.34 mmol) and the corresponding phenylacetic acid (9.18 
mmol) in dimethyl sulfoxide (15 mL) was prepared. N,N’-dicyclohexylcarbodiimide 
(11.46 mmol) was added and the mixture was heated in an oil-bath at 110 ºC for 24 h. 
Triturate ice (100 mL) and acetic acid (10 mL) were added to the reaction mixture. 
After keeping it at room temperature for 2 h, the mixture was extracted with ether (3 x 
25 mL). The organic layer was extracted with sodium bicarbonate solution (50 mL, 5 
%) and then water (20 mL). The solvent was evaporated under vacuum and the dry 
residue was purified by FC (hexane/ethyl acetate 9:1). 
  




H NMR (CDCl3) δ 
(ppm), J (Hz): 1.50 (t, 3H, -CH3, J=7.0), 4.21 (dd, 2H, -CH2, J=14.0, J=7.0), 7.09 (t, 
2H, H-6, H-7, J=6.9), 7.21 (t, 1H, H-5 J=7.8), 7.42-7.48 (m, 3H, H-3’, H-4’, H-5’), 7.72 
(dd, 2H, H-2’, H-6’, J=7.7 and J=1.4), 7.79 (s, 1H, H-4).  





(CDCl3) δ (ppm), J (Hz): 1.50 (t, 3H, -CH3, J=7.0), 3.84 (s, 3H, -OCH3), 4.19 (dd, 2H, -
CH2, J=14.0 and J=7.0), 6.84-7.26 (m, 5H, H-3’, H-5’, H-5, H-6, H-7), 7.69 (t, 2H, H-
2’, H-6’, J=7.7), 7.73 (s, 1H, H-4). 
 





(CDCl3) δ (ppm), J (Hz): 2.41 (s, 3H, -CH3), 3.82 (s, 1H, -OCH3), 7.02 (m, 2H, H-3’, 
H-4’), 7.24-7.41 (m, 5H, H-5, H-7, H-8, H-5’, H-6’) 7.69 (s, 1H, H-4).  





(CDCl3) δ (ppm), J (Hz): 2.44 (s, 3H, -CH3), 3.88 (s, 1H, -OCH3), 6.97 (m, 1H, H-4’), 
7.26-7.42 (m, 6H, H-5, H-7, H-8, H-2’, H-5’, H-6’) 7.78 (s, 1H, H-4). 
 





H NMR (CDCl3) δ (ppm), J (Hz): 2.40 (s, 3H, -CH3), 3.84 (s, 3H, -OCH3), 
6.96 (dd, 2H, H-3’, H-5’, J=6.8 and J=2.1), 7.26 (m, 3H, H-4, H-7, H-8), 7.66 (m, 3H, 
H-3, H-2’, H-6’).  
General Procedure for the Preparation of hydroxy-3-phenylcoumarins (6-10). A 
solution of substituted methoxy/ethoxy-3-phenylcoumarin (0.50 mmol) in acetic acid (5 
mL) and acetic anhydride (5 mL), at 0 ºC, was prepared. Hydriodic acid 57 % (10 mL) 
was added dropwise. The mixture was stirred, under reflux temperature, for 3 h. The 
solvent was evaporated under vacuum and the dry residue was purified by CH3CN 
crystallization.  




H NMR (DMSO-d6) 
δ (ppm), J (Hz): 7.10-7.19 (m, 3H, H-5, H-6, H-7), 7.38-7.45 (m, 3H, H-3’, H-4’, H-5’), 
7.71 (d, 2H, H-2’, H-6’, J=6.7), 8.19 (s, 1H, H-4), 10.25 (s, 1H, -OH). 





(DMSO-d6) δ (ppm), J (Hz): 6.84-6.97 (m, 2H, H-3’, H-5’), 7.00-7.12 (m, 3H, H-5, H-
6, H-7), 7.53-7.61 (m, 2H, H-2’, H-6’), 8.05 (s, 1H, H-4), 9.80 (s, 1H, -OH), 10.15 (s, 
1H, -OH). 





(DMSO-d6) 2.38 (s, 3H, -CH3), 6.30-6.35 (m, 2H, H-3’, H-5’), 7.22-7.24 (d, 1H, H-5, 
J=1.5), 7.29-7.31 (m, 2H, H-4’, H-6’), 7.34 (d, 1H, H-8, J=8.4), 7.44 (dd, 1H, H-7, 
J=8.4 and J=1.5), 7.97 (s, 1H, H-4), 9.60 (s, 1H, -OH). 
 





(DMSO-d6) 2.32 (s, 3H, -CH3), 6.77 (dd, 1H, H-4’, J=7.1 and J=2.4), 7.05-7.07 (m, 2H, 
H-5, H-8), 7.21-7.25 (m, 2H, H-5’, H-6’), 7.38 (dd, 1H, H-7, J=8.5 and J=1.8), 7.50 (s, 
1H, H-2’), 8.08 (s, 1H, H-4), 9.52 (s, 1H, -OH).  





NMR (CDCl3) δ (ppm), J (Hz): 2.37 (s, 3H, -CH3), 6.84 (d, 2H, H-3’, H-5’, J=8.8), 7.31 
(d, 1H, H-8, J=8.4), 7.40 (dd, 1H, H-7, J=8.4 and 1.9), 7.56 (m, 3H, H-2’, H-6’, H-5), 
8.06 (s, 1H, H-4).  
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